One-glance verdict
Not enough data
Fair value unavailable
Not enough cash-flow history to value this one with our method.
Fundamentals snapshot
Astrotech Corporation
ASTC · NCM · Technology · Scientific & Technical Instruments
Current price
$4.32
52-week range
$1.92 - $68.85
Market cap
$9.07M
Balance sheet
Healthy
-30.02x Concerning
Net cash $9.03M. Interest coverage shows how many times profit covers the interest bill.
What stands out
0 Rewards
2 Risks
0 rewards · 2 risks
- Risk Operating margin compressed from -1474.7% to -2577.8% over 3 years.
- Risk Return on equity was -75.4% last year — the company lost money on shareholders' equity.
What this company does
Astrotech Corporation
Astrotech Corporation makes and sells scientific equipment used to identify different substances, like explosives, drugs, and compounds in breath or the environment. Their main income comes from selling these specialized machines used in security, environmental testing, and the cannabis industry. Understanding their sales helps us see if these industries are growing and if Astrotech's technology is in demand.
How the company got here
Astrotech Corporation, originally founded in 1984 as SPACEHAB, Inc., has a history rooted in supporting NASA's space exploration efforts. Initially, it provided equipment and services for microgravity experiments on the Space Shuttle. As the Space Shuttle program concluded, the company strategically shifted its focus. It began to emphasize its spacecraft processing business, Astrotech Space Operations, and its burgeoning mass spectrometer technology through a subsidiary called 1st Detect. In 2009, the company officially changed its name to Astrotech Corporation to better reflect its evolving business. A significant part of its history includes the sale of its satellite processing operations to Lockheed Martin in 2014, allowing Astrotech to concentrate more on its core technology development.
What it actually does
At its core, Astrotech Corporation is a technology company that develops and commercializes scientific instruments, primarily based on mass spectrometry technology. Think of mass spectrometry as a highly advanced way to identify and measure different substances by looking at their weight and electrical charge. Astrotech takes this sophisticated science and turns it into practical tools for various industries. These tools are designed to be precise, reliable, and often rugged enough to work in challenging environments, from security checkpoints to industrial settings.
1st Detect
This business segment focuses on developing and manufacturing sophisticated trace detectors. These are devices designed to identify tiny amounts of specific substances, like explosives and narcotics. The main product here is the TRACER 1000, which uses mass spectrometry to detect these substances. These detectors are crucial for security operations at places like airports, border crossings, and cargo hubs, helping to keep people and places safe. Sales from these detectors, along with ongoing maintenance services, contribute to the company's revenue.
AgLAB
AgLAB is Astrotech's venture into applying mass spectrometry to the agricultural sector, particularly the hemp and cannabis market. Their instruments, like the AgLAB 1000, are developed to help optimize processes within this industry, such as improving the efficiency of distillation. This segment also includes the development of the BreathTest-1000, a device that analyzes breath to screen for certain compounds that might indicate a health condition. This shows how Astrotech is diversifying its technology into health-related applications.
EN-SCAN
The EN-SCAN line of products is dedicated to environmental testing and monitoring. These instruments, including handheld and rugged lab-based gas chromatography-mass spectrometry (GC-MS) devices, are designed for instant, on-site analysis of environmental conditions. This means they can be used to detect and measure substances in the air or other environmental samples directly where the testing is needed, rather than having to send samples to a distant laboratory. This provides rapid insights for environmental safety and compliance.
What management is betting on now
Astrotech's management is focused on leveraging its core mass spectrometry technology to create and grow specialized businesses. They are betting on the versatility of their technology to address critical needs in security, environmental monitoring, and specialized industrial applications like the cannabis market. The strategy involves developing innovative, often miniaturized and ruggedized, instruments that offer laboratory-level precision in real-world settings. By commercializing these technologies through distinct subsidiaries, Astrotech aims to capture value across a range of growing markets.
Price history
How the share price has moved
—
Loading price history…
Earnings history
Last 8 quarters — what happened
Click any quarter to read the call summary and what the numbers say.
FY2025 Q1
$-3.88M
FY2025 Q2
$-3.36M
FY2025 Q3
$-3.89M
FY2025 Q4
$-2.71M
FY2026 Q1
$-4.38M
FY2026 Q2
$-3.95M
FY2026 Q3
$-3.69M
FY2026 Q4
$-2.31M
Revenue
—
Net income
$-3.27M
Diluted EPS
—
Operating cash flow
$-2.29M
Free cash flow
$-2.31M
Fetching…
Sources
Revenue
—
Net income
$-3.77M
Diluted EPS
—
Operating cash flow
$-3.69M
Free cash flow
$-3.69M
Fetching…
Sources
Revenue
—
Net income
$-3.93M
Diluted EPS
—
Operating cash flow
$-3.54M
Free cash flow
$-3.95M
Fetching…
Sources
Revenue
—
Net income
$-3.46M
Diluted EPS
—
Operating cash flow
$-3.94M
Free cash flow
$-4.38M
Fetching…
Sources
Revenue
$1.00M
Net income
$-2.93M
Diluted EPS
—
Operating cash flow
$-2.36M
Free cash flow
$-2.71M
Fetching…
Sources
Revenue
—
Net income
$-3.63M
Diluted EPS
—
Operating cash flow
$-3.86M
Free cash flow
$-3.89M
Fetching…
Sources
Revenue
—
Net income
$-4.01M
Diluted EPS
—
Operating cash flow
$-3.04M
Free cash flow
$-3.36M
Fetching…
Sources
Revenue
—
Net income
$-3.28M
Diluted EPS
—
Operating cash flow
$-3.69M
Free cash flow
$-3.88M
Fetching…
Sources
Is it cheap or expensive?
Fair value — vs current price $4.32
We couldn't calculate a fair value right now.
Is it drowning in debt?
Healthy
Net cash $9.0M - more cash than debt. Interest coverage -30.0x.
Net debt
$-9.03M
Interest coverage
-30.02x
Astrotech Corporation is healthier than 0 of 1 peers on balance-sheet leverage.
Healthy
Worse cushion
Baseline
Better cushion
ASTC
BASELINE
Astrotech Corporation
Total debt $2.31M Interest coverage -30.02x This is the baseline the peer rows are being compared against.
What you should know
The case for and against ASTC
0 Rewards
2 Risks
Rewards
Risks
-
Operating margin compressed from -1474.7% to -2577.8% over 3 years.
-
Return on equity was -75.4% last year — the company lost money on shareholders' equity.
The numbers
All the key metrics, grouped by purpose
Tap any ? icon to learn what it means.
Valuation
How expensive the stock looks
P/E (TTM)
—
Forward P/E
-6.35x
P/B
0.52x
P/S
9.94x
EV/EBITDA
0.01x
PEG ratio
1.02x
Profitability
How much profit each dollar creates
Gross margin
23.8%
Operating margin
-2,577.8%
Net margin
0.0%
ROE
-75.4%
ROA
-37.2%
Health
Liquidity and balance-sheet strength
Debt / equity
0.14x
Current ratio
7.06x
Quick ratio
5.08x
Total debt
$2.31M
Total cash
$11.33M
Growth
How the business has been compounding
Revenue TTM
$4.13M
Revenue 5Y CAGR
31.5%
EPS TTM
-8.49
EPS 5Y CAGR
—
Cash flow
How much cash the business throws off
Operating CF TTM
$-13.45M
Free CF TTM
$-14.33M
FCF margin
-346.9%
Dividend
Shareholder payout
Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—